Distinctive effects of plant protein sources on renal disease progression and associated cardiac hypertrophy in experimental kidney disease

Molecular Nutrition and Food Research

Volumn 55, Issue 7, 2011, Pages 1044-1051

  Aukema, Harold M ^a   Gauthier, Joy ^a   Roy, Manon ^a   Jia, Yong ^a   Li, Huan ^a   Aluko, Rotimi E ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Cardiac hypertrophy; Hemp protein; Kidney disease; Pea protein; Soy protein

Indexed keywords

CANNABIS; CASEIN; CCR2 PROTEIN, RAT; CHEMOKINE RECEPTOR CCR2; CREATININE; SOYBEAN PROTEIN; VEGETABLE PROTEIN;

ANIMAL; ARTICLE; BLOOD; BODY WEIGHT; CARDIOMEGALY; CHEMISTRY; DISEASE MODEL; DRUG EFFECT; FIBROSIS; GROWTH, DEVELOPMENT AND AGING; KIDNEY; KIDNEY DISEASE; LIVER; METABOLISM; ORGAN SIZE; PATHOLOGY; PEA; RAT;

ANIMALS; BODY WEIGHT; CANNABIS; CARDIOMEGALY; CASEINS; CREATININE; DISEASE MODELS, ANIMAL; FIBROSIS; KIDNEY; KIDNEY DISEASES; LIVER; ORGAN SIZE; PEAS; RATS; RECEPTORS, CCR2; SOYBEAN PROTEINS; VEGETABLE PROTEINS;

ANIMALIA; CANNABIS SATIVA; PISUM SATIVUM; RATTUS;

EID: 79959994503     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201000558     Document Type: Article

References (59)

1. Coresh, J., Selvin, E., Stevens, L. A., Manzi, J. et al., Prevalence of chronic kidney disease in the United States. J. Am. Med. Assoc. 2007, 298, 2038-2047.
2. Mitch, W. E., Remuzzi, G., Diets for patients with chronic kidney disease, still worth prescribing. J. Am. Soc. Nephrol. 2004, 15, 234-237.
3. Walser, M., Mitch, W. E., Maroni, B. J., Kopple, J. D., Should protein intake be restricted in predialysis patients? Kidney Int. 1999, 55, 771-777.
4. Knight, E. L., Stampfer, M. J., Hankinson, S. E., Spiegelman, D., Curhan, G. C., The impact of protein intake on renal function decline in women with normal renal function or mild renal insufficiency. Ann. Intern. Med. 2003, 138, 460-467.
5. Kontessis, P. A., Bossinakou, I., Sarika, L., Iliopoulou, E. et al., Renal, metabolic, and hormonal responses to proteins of different origin in normotensive, nonproteinuric type I diabetic patients. Diabetes Care 1995, 18, 1233.
6. Kontessis, P., Jones, S., Dodds, R., Trevisan, R. et al., Renal, metabolic and hormonal responses to ingestion of animal and vegetable proteins. Kidney Int. 1990, 38, 136-144.
7. Barsotti, G., Morelli, E., Cupisti, A., Meola, M. et al., A low-nitrogen low-phosphorus vegan diet for patients with chronic renal failure. Nephron 1996, 74, 390-394.
8. Gentile, M. G., Fellin, G., Cofano, F., Delle Fave, A. et al., Treatment of proteinuric patients with a vegetarian soy diet and fish oil. Clin. Nephrol. 1993, 40, 315-320.
9. Jibani, M. M., Bloodworth, L. L., Foden, E., Griffiths, K. D., Galpin, O. P., Predominantly vegetarian diet in patients with incipient and early clinical diabetic nephropathy: effects on albumin excretion rate and nutritional status. Diabet. Med. 1991, 8, 949-953.
10. Stephenson, T. J., Setchell, K. D., Kendall, C. W., Jenkins, D. J. et al., Effect of soy protein-rich diet on renal function in young adults with insulin-dependent diabetes mellitus. Clin. Nephrol. 2005, 64, 1-11.
11. Teixeira, S. R., Tappenden, K. A., Erdman, J. W., Jr., Altering dietary protein type and quantity reduces urinary albumin excretion without affecting plasma glucose concentrations in BKS.cg-m+Lepr db/+Lepr db (db/db) mice. J. Nutr. 2003, 133, 673-678.
12. Azadbakht, L., Esmaillzadeh, A., Soy-protein consumption and kidney-related biomarkers among type 2 diabetics: a crossover, randomized clinical trial. J. Ren. Nutr. 2009, 19, 479-486.
13. Azadbakht, L., Atabak, S., Esmaillzadeh, A., Soy protein intake, cardiorenal indices, and C-reactive protein in type 2 diabetes with nephropathy: a longitudinal randomized clinical trial. Diab. Care 2008, 31, 648-654.
14. Azadbakht, L., Shakerhosseini, R., Atabak, S., Jamshidian, M. et al., Beneficiary effect of dietary soy protein on lowering plasma levels of lipid and improving kidney function in type II diabetes with nephropathy. Eur. J. Clin. Nutr. 2003, 57, 1292-1294.
15. Maddox, D. A., Alavi, F. K., Silbernick, E. M., Zawada, E. T., Protective effects of a soy diet in preventing obesity-linked renal disease. Kidney Int. 2002, 61, 96-104.
16. Hwang, S. Y., Taylor, C. G., Zahradka, P., Bankovic-Calic, N. et al., Dietary soy protein reduces early renal disease progression and alters prostanoid production in obese fa/fa Zucker rats. J. Nutr. Biochem. 2008, 19, 255-262.
17. Williams, A. J., Baker, F., Walls, J., Effect of varying quantity and quality of dietary protein intake in experimental renal disease in rats. Nephron 1987, 46, 83-90.
18. Chen, S. T., Peng, S. J., Chen, J. R., Effects of dietary protein on renal function and lipid metabolism in five-sixths nephrectomized rats. Br. J. Nutr. 2003, 89, 491-497.
19. Pedraza-Chaverri, J., Barrera, D., Hernandez-Pando, R., Medina-Campos, O. N. et al., Soy protein diet ameliorates renal nitrotyrosine formation and chronic nephropathy induced by puromycin aminonucleoside. Life Sci. 2004, 74, 987-999.
20. Iwasaki, K., Gleiser, C. A., Masoro, E. J., McMahan, C. A. et al., The influence of dietary protein source on longevity and age-related disease processes of Fischer rats. J. Gerontol. 1988, 43, B5-B12.
21. Aukema, H. M., Housini, I., Rawling, J. M., Dietary soy protein effects on inherited polycystic kidney disease are influenced by gender and protein level. J. Am. Soc. Nephrol. 1999, 10, 300-308.
22. Tomobe, K., Philbrick, D. J., Ogborn, M. R., Takahashi, H., Holub, B. J., Effect of dietary soy protein and genistein on disease progression in mice with polycystic kidney disease. Am. J. Kidney Dis. 1998, 31, 55-61.
23. CowleyJr, B. D., Gudapaty, S., Kraybill, A. L., Barash, B. D. et al., Autosomal-dominant polycystic kidney disease in the rat. Kidney Int. 1993, 43, 522-534.
24. Gretz, N., Ceccherini, I., Kranzlin, B., Kloting, I. et al., Gender-dependent disease severity in autosomal polycystic kidney disease of rats. Kidney Int. 1995, 48, 496-500.
25. Grantham, J. J., Clinical practice. Autosomal dominant polycystic kidney disease. N. Engl. J. Med. 2008, 359, 1477-1485.
26. Harris, P. C., Torres, V. E., Polycystic kidney disease. Annu. Rev. Med. 2009, 60, 321-337.
27. Fair, D. E., Ogborn, M. R., Weiler, H. A., Bankovic-Calic, N. et al., Dietary soy protein attenuates renal disease progression after 1 and 3 weeks in Han:SPRD-cy weanling rats. J. Nutr. 2004, 134, 1504-1507.
28. Aukema, H. M., Housini, I., Dietary soy protein effects on disease and IGF-I in male and female Han:SPRD-cy rats. Kidney Int. 2001, 59, 52-61.
29. Ogborn, M. R., Bankovic-Calic, N., Shoesmith, C., Buist, R., Peeling, J., Soy protein modification of rat polycystic kidney disease. Am. J. Physiol. 1998, 274, F541-F549.
30. Ogborn, M. R., Nitschmann, E., Weiler, H. A., Bankovic-Calic, N., Modification of polycystic kidney disease and fatty acid status by soy protein diet. Kidney Int. 2000, 57, 159-166.
31. Zerres, K., Volpel, M. C., Weiss, H., Cystic kidneys. Genetics, pathologic anatomy, clinical picture, and prenatal diagnosis. Hum. Genet. 1984, 68, 104-135.
32. Reeves, P. G., Nielsen, F. H., Fahey, G. C., Jr., AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 1993, 123, 1939-1151.
33. Markwell, M. A., Haas, S. M., Bieber, L. L., Tolbert, N. E., A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 1978, 87, 206-210.
34. Heinegard, D., Tiderstrom, G., Determination of serum creatinine by a direct colorimetric method. Clin. Chim. Acta 1973, 43, 305-310.
35. Bradford, M. M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254.
36. Ogborn, M. R., Nitschmann, E., Bankovic-Calic, N., Weiler, H. A., Aukema, H. M., Dietary flax oil reduces renal injury, oxidized LDL content, and tissue n-6/n-3 FA ratio in experimental polycystic kidney disease. Lipids 2002, 37, 1059-1065.
37. Sankaran, D., Lu, J., Bankovic-Calic, N., Ogborn, M. R., Aukema, H. M., Modulation of renal injury in pcy mice by dietary fat containing n-3 fatty acids depends on the level and type of fat. Lipids 2004, 39, 207-214.
38. 2 and cyclooxygenases in polycystic kidney disease. FASEB J. 2003, 17, 298-300.
39. Warford-Woolgar, L., Peng, C. Y., Shuhyta, J., Wakefield, A. et al., Selectivity of cyclooxygenase isoform activity and prostanoid production in normal and diseased Han:SPRD-cy rat kidneys. Am. J. Physiol. Renal Physiol. 2006, 290, F897-F904.
40. Aukema, H. M., Ogborn, M. R., Tomobe, K., Takahashi, H. et al., Effects of dietary protein restriction and oil type on the early progression of murine polycystic kidney disease. Kidney Int. 1992, 42, 837-842.
41. Ogborn, M. R., Sareen, S., Amelioration of polycystic kidney disease by modification of dietary protein intake in the rat. J. Am. Soc. Nephrol. 1995, 6, 1649-1654.
42. Hunsicker, L. G., Adler, S., Caggiula, A., England, B. K. et al., Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int. 1997, 51, 1908-1919.
43. Levey, A. S., Greene, T., Sarnak, M. J., Wang, X. et al., Effect of dietary protein restriction on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. Am. J. Kidney Dis. 2006, 48, 879-888.
44. Klahr, S., Morrissey, J., L-arginine as a therapeutic tool in kidney disease. Semin. Nephrol. 2004, 24, 389-394.
45. Cherla, G., Jaimes, E. A., Role of L-arginine in the pathogenesis and treatment of renal disease. J. Nutr. 2004, 134, 2801S-2806S; discussion 2818S-2819S.
46. Friedman, M., Brandon, D. L., Nutritional and health benefits of soy proteins. J. Agric. Food Chem. 2001, 49, 1069-1086.
47. Velasquez, M. T., Bhathena, S. J., Dietary phytoestrogens: a possible role in renal disease protection. Am. J. Kidney Dis. 2001, 37, 1056-1068.
48. Ogborn, M. R., Nitschmann, E., Bankovic-Calic, N., Weiler, H., Aukema, H. M., Dietary soy protein benefit in experimental kidney disease is preserved after isoflavone depletion of diet. Exp. Biol. Med. 2010, 235, 1315-1320.
49. Kalantar-Zadeh, K., Gutekunst, L., Mehrotra, R., Kovesdy, C. P. et al., Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. Clin. J. Am. Soc. Nephrol. 2010, 5, 519-530.
50. Kluth, D. C., Erwig, L. P., Rees, A. J., Multiple facets of macrophages in renal injury. Kidney Int. 2004, 66, 542-557.
51. Sean Eardley, K., Cockwell, P., Macrophages and progressive tubulointerstitial disease. Kidney Int. 2005, 68, 437-455.
52. Tarabra, E., Giunti, S., Barutta, F., Salvidio, G. et al., Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes. Diabetes 2009, 58, 2109-2118.
53. McIntosh, L. M., Barnes, J. L., Barnes, V. L., McDonald, J. R., Selective CCR2-targeted macrophage depletion ameliorates experimental mesangioproliferative glomerulonephritis. Clin. Exp. Immunol. 2009, 155, 295-303.
54. Elmarakby, A. A., Quigley, J. E., Olearczyk, J. J., Sridhar, A. et al., Chemokine receptor 2b inhibition provides renal protection in angiotensin II - salt hypertension. Hypertension 2007, 50, 1069-1076.
55. Kitagawa, K., Wada, T., Furuichi, K., Hashimoto, H. et al., Blockade of CCR2 ameliorates progressive fibrosis in kidney. Am. J. Pathol. 2004, 165, 237-246.
56. Segerer, S., Cui, Y., Hudkins, K. L., Goodpaster, T. et al., Expression of the chemokine monocyte chemoattractant protein-1 and its receptor chemokine receptor 2 in human crescentic glomerulonephritis. J. Am. Soc. Nephrol. 2000, 11, 2231-2242.
57. Foley, R. N., Parfrey, P. S., Sarnak, M. J., Clinical epidemiology of cardiovascular disease in chronic renal disease. Am. J. Kidney Dis. 1998, 32, S112-S119.
58. Matsushita, K., Selvin, E., Bash, L. D., Franceschini, N. et al., Change in estimated GFR associates with coronary heart disease and mortality. J. Am. Soc. Nephrol. 2009, 20, 2617-2624.
59. Sarnak, M. J., Levey, A. S., Schoolwerth, A. C., Coresh, J. et al., Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003, 108, 2154-2169.